Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Faster global financial news!
Foreign media: AbbVie is in talks to acquire Revolution Medicines, with a valuation potentially exceeding $20 billion
07/01/2026 06:59
Complaint Report
Complaint Report
On January 7, Eastern Time, The Wall Street Journal reported that AbbVie is in advanced talks to acquire Revolution Medicines, a biotechnology company specializing in cancer drugs, with a valuation potentially reaching $20 billion or more. The report stated that a deal could be reached soon, barring any last-minute obstacles.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Previous: Mexican President: Mexico Will Become a Major Supplier of Crude Oil to Cuba
|
U.S. Treasury Secretary Bessent: Eligible taxpayers may claim an annual deduction of up to $10,000 for auto loan interest on new vehicles assembled in the United States that are purchased between 2025 and 2028.: Next
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
Scan to Download App
